Johnson & Johnson's forex warning a sign for rival drugmakers
January 20, 2015 at 18:06 PM EST
Jan 20 (Reuters) - Johnson & Johnson surprised investors by detailing the degree to which a strong dollar will hurt sales abroad this year, and industry watchers say Wall Street is underestimating the likely hit to other U.S.-based rivals such as Pfizer Inc and Merck & Co.